Results 281 to 290 of about 159,586 (333)
Salivary Proteomic Signatures in Pregnant Women With Excessive Gingival Bleeding
ABSTRACT Objective This observational, cross‐sectional, and analytical study aimed to explore the pathophysiological mechanisms of gingivitis in pregnancy by analyzing the salivary proteomic profile according to gingival bleeding status. Materials and Methods Pregnant women at the 27th week of gestation or beyond were categorized into two groups: those
Gerson Aparecido Foratori‐Junior +9 more
wiley +1 more source
Nanovaccines in gastrointestinal cancers. [PDF]
Wang Y, Huang P, Li C, Tu S, Yang H.
europepmc +1 more source
Abstract Orthotopic allograft transplantation (OAT) is a significant approach to addressing organ failure. However, persistent immune responses to the allograft affect chronic rejection, which induces OAT vasculopathy (OATV) and organ failure. Porphyromonas gingivalis can infiltrate remote organs via the bloodstream, thereby intensifying the severity ...
Chien‐Sung Tsai +7 more
wiley +1 more source
Harnessing blue light photobiomodulation for cancer therapy: Evidence from a systematic review
Conventional treatments for various types of cancer are often associated with tumor recurrence and aggressiveness. Photobiomodulation with blue light (BL; 450–470 nm) emerges as a promising alternative with antitumor effects. This systematic review, with 37 in vitro and in vivo studies from 2002 to 2024, revealed that BL reduces cell viability ...
Bárbara Evelyn Santos de Lima +6 more
wiley +1 more source
Immunotherapy for Solid Tumours: Current Clinical Landscape and Future Directions.
van Diepen AE +3 more
europepmc +1 more source
Immunocompatibility in transplantation: adapting to a changing therapeutic landscape. [PDF]
Güell-Alonso R +2 more
europepmc +1 more source
Biological mechanism and immune response of MHC-II expression in tumor cells. [PDF]
Zhou M, Pan S, Zhang Y, Hu C, Xu Z.
europepmc +1 more source
Knowledge-based immune-therapeutic advances for transplantation and cancer. [PDF]
Simpson E.
europepmc +1 more source
Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy. [PDF]
Anilkumar AS +2 more
europepmc +1 more source

